Brief: Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates
06/11/2024 13:37
Nov 6 (Reuters) - Sonnet Biotherapeutics Holdings Inc
SONN.O :
* SONNET BIOTHERAPEUTICS ANNOUNCES ISSUANCE OF U.S. PATENT
COVERING A VARIANT IL-18 INCORPORATED INTO TWO NOVEL
IMMUNOTHERAPEUTIC DRUG CANDIDATES
* SONNET BIOTHERAPEUTICS HOLDINGS INC - PATENT TERM
EFFECTIVE
UNTIL JUNE 2044
Source text: ID:nGNX6jmHxy
Further company coverage: SONN.O
(Reuters.Briefs@thomsonreuters.com)